RMD — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
ResMed Inc.
Healthcare · $224.09
4.9
/10
Neutral
How this score works →
Regime
Bearish
vs SMA200
SMA200 Distance
-13.5%
Below trend
Volatility
Normal
Average premiums
Momentum
Accelerating
Price direction
About ResMed Inc.
ResMed designs and sells CPAP devices, masks, and cloud-connected software for sleep apnea and respiratory care. Recurring revenue from mask replacements and SaaS subscriptions. Pays a small dividend. GLP-1 weight-loss drug headlines create periodic panic selloffs — those IV spikes offer excellent windows for CSP entries.
Medical Devices — Sleep & Respiratory
Market Cap
$32.7B
P/E Ratio
22.2
Dividend
107.00%
Beta
0.93
52-Week Range Current: $224.09
$199.92 $293.81
Earnings
2026-04-30
25 days away
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE